Comparison of Virological and Immunological Results of Efavirenz-based Regimen in HIV-infected Patients With or Without Allergic Reactions to Nevirapine.
Phase of Trial: Phase IV
Latest Information Update: 14 Mar 2011
At a glance
- Drugs Efavirenz (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 14 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Mar 2011 Planned end date changed from 1 Apr 2010 to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 15 Jan 2010 New trial record